Czechia, Jan. 6 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni nemocnice Plzen for Antineoplastic and immunomodulating agents - Imunopreparaty 2025-II. The value of the contract is worth 7665178800 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....